These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2327573)

  • 21. Modulation of ppp(A2'p)nA-dependent RNase by a temperature-sensitive mutant of vaccinia virus.
    Cohrs RJ; Condit RC; Pacha RF; Thompson CL; Sharma OK
    J Virol; 1989 Feb; 63(2):948-51. PubMed ID: 2911126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of 2',5'-oligo(A)-dependent endoribonuclease by 2',5'-oligo(A) degradation products.
    Williams GJ; De Benedetti A; Baglioni C
    Virology; 1986 Jun; 151(2):233-42. PubMed ID: 2422811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-5A-dependent RNase molecules dimerize during activation by 2-5A.
    Dong B; Silverman RH
    J Biol Chem; 1995 Feb; 270(8):4133-7. PubMed ID: 7876164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissection of the roles of adenine ring nitrogen (N-1) and exocyclic amino (N-6) moieties in the interaction of 2-5A with RNase L.
    Player MR; Kalinichenko EN; Podkopaeva TL; Mikhailopulo IA; Seela F; Torrence PF
    Biochem Biophys Res Commun; 1998 Apr; 245(2):430-4. PubMed ID: 9571169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of 2',5'-oligoadenylate analogs containing an adenine acyclonucleoside and their ability to activate human RNase L.
    Ueno Y; Ishihara S; Ito Y; Kitade Y
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4431-4. PubMed ID: 15357966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of 2-5As possessing base-modified adenosines and their activities to human recombinant RNase L.
    Kitade Y; Tanida Y; Tuboi T; Yoshimura A; Nakanishi M; Yatome C
    Nucleic Acids Symp Ser; 2000; (44):29-30. PubMed ID: 12903252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.
    Malathi K; Paranjape JM; Bulanova E; Shim M; Guenther-Johnson JM; Faber PW; Eling TE; Williams BR; Silverman RH
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14533-8. PubMed ID: 16203993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. rRNA cleavage as an index of ppp(A2'p)nA activity in interferon-treated encephalomyocarditis virus-infected cells.
    Silverman RH; Skehel JJ; James TC; Wreschner DH; Kerr IM
    J Virol; 1983 Jun; 46(3):1051-5. PubMed ID: 6190010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue-related and species-specific differences in the 2-5A oligomer size requirement for activation of 2-5A-dependent RNase.
    Krause D; Silverman RH
    J Interferon Res; 1993 Feb; 13(1):13-6. PubMed ID: 8454906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system.
    Castelli JC; Hassel BA; Wood KA; Li XL; Amemiya K; Dalakas MC; Torrence PF; Youle RJ
    J Exp Med; 1997 Sep; 186(6):967-72. PubMed ID: 9294150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional analysis of 2-5A-dependent RNase and 2-5a using 2',5'-oligoadenylate-cellulose.
    Silverman RH
    Anal Biochem; 1985 Feb; 144(2):450-60. PubMed ID: 3993910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 8-Methyladenosine-substituted analogues of 2-5A: synthesis and their biological activities.
    Kitade Y; Nakata Y; Hirota K; Maki Y; Pabuccuoglu A; Torrence PF
    Nucleic Acids Res; 1991 Aug; 19(15):4103-8. PubMed ID: 1714563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2',5'-Oligoadenylate size is critical to protect RNase L against proteolytic cleavage in chronic fatigue syndrome.
    Frémont M; El Bakkouri K; Vaeyens F; Herst CV; De Meirleir K; Englebienne P
    Exp Mol Pathol; 2005 Jun; 78(3):239-46. PubMed ID: 15924878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrence of 2-5A and RNA degradation in the chick oviduct during rapid estrogen withdrawal.
    Cohrs RJ; Goswami BB; Sharma OK
    Biochemistry; 1988 May; 27(9):3246-52. PubMed ID: 2455540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respective role of each of the purine N-6 amino groups of 5'-O-triphosphoryladenylyl(2'----5')adenylyl(2----5')adenosine in binding to and activation of RNase L.
    Imai J; Lesiak K; Torrence PF
    J Biol Chem; 1985 Feb; 260(3):1390-3. PubMed ID: 2981855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.
    Player MR; Torrence PF
    Pharmacol Ther; 1998 May; 78(2):55-113. PubMed ID: 9623881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Affinity labelling and characterization of the ppp(A2'p)nA-dependent endoribonuclease from different mammalian sources.
    Wreschner DH; Silverman RH; James TC; Gilbert CS; Kerr IM
    Eur J Biochem; 1982 May; 124(2):261-8. PubMed ID: 6284502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon action. Covalent linkage of (2'-5')pppApApA(32P)pCp to (2'-5')(A)n-dependent ribonucleases in cell extracts by ultraviolet irradiation.
    Floyd-Smith G; Yoshie O; Lengyel P
    J Biol Chem; 1982 Aug; 257(15):8584-7. PubMed ID: 6178733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-5A induces a conformational change in the ankyrin-repeat domain of RNase L.
    Nakanishi M; Goto Y; Kitade Y
    Proteins; 2005 Jul; 60(1):131-8. PubMed ID: 15849753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biologically active 2-5A analogs containing 3'-O,4'-C-propylene adenosine as potent RNase L agonists.
    Morita K; Obika S; Imanishi T; Kitade Y; Koizumi M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):637-8. PubMed ID: 18776541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.